Table of Content

1 Report Overview
1.1 Animal Biological Vaccine Definition
1.2 Market by Type
1.2.1 Global Animal Biological Vaccine Market Size Growth Rate by Type, 2018 VS 2022 VS 2034
1.2.2 Oral
1.2.3 Subcutaneous
1.2.4 Intramuscular
1.2.5 Others
1.3 Market Segment by Application
1.3.1 Global Animal Biological Vaccine Market Size Growth Rate by Application, 2018 VS 2022 VS 2034
1.3.2 Porcine
1.3.3 Poultry
1.3.4 Livestock
1.3.5 Companion Animals
1.3.6 Aquaculture
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Animal Biological Vaccine Sales
2.1 Global Animal Biological Vaccine Revenue Estimates and Forecasts 2018-2034
2.2 Global Animal Biological Vaccine Revenue by Region: 2018 VS 2022 VS 2034
2.3 Global Animal Biological Vaccine Revenue by Region
2.3.1 Global Animal Biological Vaccine Revenue by Region (2018-2024)
2.3.2 Global Animal Biological Vaccine Revenue by Region (2024-2034)
2.4 Global Animal Biological Vaccine Sales Quantity Estimates and Forecasts 2018-2034
2.5 Global Animal Biological Vaccine Sales Quantity by Region: 2018 VS 2022 VS 2034
2.6 Global Animal Biological Vaccine Sales Quantity by Region
2.6.1 Global Animal Biological Vaccine Sales Quantity by Region (2018-2024)
2.6.2 Global Animal Biological Vaccine Sales Quantity by Region (2024-2034)
2.7 North America
2.8 Europe
2.9 China
2.10 APAC (excluding China)
2.11 Middle East, Africa and Latin America
3 Competition by Manufacturers
3.1 Global Animal Biological Vaccine Sales Quantity by Manufacturers
3.1.1 Global Animal Biological Vaccine Sales Quantity by Manufacturers (2018-2024)
3.1.2 Global Animal Biological Vaccine Sales Quantity Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Companies by Animal Biological Vaccine Sales in 2022
3.2 Global Animal Biological Vaccine Revenue by Manufacturers
3.2.1 Global Animal Biological Vaccine Revenue by Manufacturers (2018-2024)
3.2.2 Global Animal Biological Vaccine Revenue Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Animal Biological Vaccine Revenue in 2022
3.3 Global Animal Biological Vaccine Sales Price by Manufacturers
3.4 Global Key Players of Animal Biological Vaccine, Industry Ranking, 2021 VS 2022
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Animal Biological Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Animal Biological Vaccine, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Animal Biological Vaccine, Product Offered and Application
3.8 Global Key Manufacturers of Animal Biological Vaccine, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Estimates and Forecasts by Type
4.1 Global Animal Biological Vaccine Sales Quantity by Type
4.1.1 Global Animal Biological Vaccine Historical Sales Quantity by Type (2018-2024)
4.1.2 Global Animal Biological Vaccine Forecasted Sales Quantity by Type (2024-2034)
4.1.3 Global Animal Biological Vaccine Sales Quantity Market Share by Type (2018-2034)
4.2 Global Animal Biological Vaccine Revenue by Type
4.2.1 Global Animal Biological Vaccine Historical Revenue by Type (2018-2024)
4.2.2 Global Animal Biological Vaccine Forecasted Revenue by Type (2024-2034)
4.2.3 Global Animal Biological Vaccine Revenue Market Share by Type (2018-2034)
4.3 Global Animal Biological Vaccine Price by Type
4.3.1 Global Animal Biological Vaccine Price by Type (2018-2024)
4.3.2 Global Animal Biological Vaccine Price Forecast by Type (2024-2034)
5 Market Size by Application
5.1 Global Animal Biological Vaccine Sales Quantity by Application
5.1.1 Global Animal Biological Vaccine Historical Sales Quantity by Application (2018-2024)
5.1.2 Global Animal Biological Vaccine Forecasted Sales Quantity by Application (2024-2034)
5.1.3 Global Animal Biological Vaccine Sales Quantity Market Share by Application (2018-2034)
5.2 Global Animal Biological Vaccine Revenue by Application
5.2.1 Global Animal Biological Vaccine Historical Revenue by Application (2018-2024)
5.2.2 Global Animal Biological Vaccine Forecasted Revenue by Application (2024-2034)
5.2.3 Global Animal Biological Vaccine Revenue Market Share by Application (2018-2034)
5.3 Global Animal Biological Vaccine Price by Application
5.3.1 Global Animal Biological Vaccine Price by Application (2018-2024)
5.3.2 Global Animal Biological Vaccine Price Forecast by Application (2024-2034)
6 North America
6.1 North America Animal Biological Vaccine Sales by Company
6.1.1 North America Animal Biological Vaccine Revenue by Company (2018-2024)
6.1.2 North America Animal Biological Vaccine Sales Quantity by Company (2018-2024)
6.2 North America Animal Biological Vaccine Market Size by Type
6.2.1 North America Animal Biological Vaccine Sales Quantity by Type (2018-2034)
6.2.2 North America Animal Biological Vaccine Revenue by Type (2018-2034)
6.3 North America Animal Biological Vaccine Market Size by Application
6.3.1 North America Animal Biological Vaccine Sales Quantity by Application (2018-2034)
6.3.2 North America Animal Biological Vaccine Revenue by Application (2018-2034)
6.4 North America Animal Biological Vaccine Market Size by Country
6.4.1 North America Animal Biological Vaccine Revenue by Country: 2018 VS 2022 VS 2034
6.4.2 North America Animal Biological Vaccine Revenue by Country (2018-2034)
6.4.3 North America Animal Biological Vaccine Sales Quantity by Country (2018-2034)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Animal Biological Vaccine Sales by Company
7.1.1 Europe Animal Biological Vaccine Sales Quantity by Company (2018-2024)
7.1.2 Europe Animal Biological Vaccine Revenue by Company (2018-2024)
7.2 Europe Animal Biological Vaccine Market Size by Type
7.2.1 Europe Animal Biological Vaccine Sales Quantity by Type (2018-2034)
7.2.2 Europe Animal Biological Vaccine Revenue by Type (2018-2034)
7.3 Europe Animal Biological Vaccine Market Size by Application
7.3.1 Europe Animal Biological Vaccine Sales Quantity by Application (2018-2034)
7.3.2 Europe Animal Biological Vaccine Revenue by Application (2018-2034)
7.4 Europe Animal Biological Vaccine Market Size by Country
7.4.1 Europe Animal Biological Vaccine Revenue by Country: 2018 VS 2022 VS 2034
7.4.2 Europe Animal Biological Vaccine Revenue by Country (2018-2034)
7.4.3 Europe Animal Biological Vaccine Sales Quantity by Country (2018-2034)
7.4.4 Germany
7.4.5 France
7.4.6 U.K.
7.4.7 Italy
7.4.8 Russia
8 China
8.1 China Animal Biological Vaccine Sales by Company
8.1.1 China Animal Biological Vaccine Sales Quantity by Company (2018-2024)
8.1.2 China Animal Biological Vaccine Revenue by Company (2018-2024)
8.2 China Animal Biological Vaccine Market Size by Type
8.2.1 China Animal Biological Vaccine Sales Quantity by Type (2018-2034)
8.2.2 China Animal Biological Vaccine Revenue by Type (2018-2034)
8.3 China Animal Biological Vaccine Market Size by Application
8.3.1 China Animal Biological Vaccine Sales Quantity by Application (2018-2034)
8.3.2 China Animal Biological Vaccine Revenue by Application (2018-2034)
9 APAC (excluding China)
9.1 APAC Animal Biological Vaccine Sales by Company
9.1.1 APAC Animal Biological Vaccine Sales Quantity by Company (2018-2024)
9.1.2 APAC Animal Biological Vaccine Revenue by Company (2018-2024)
9.2 APAC Animal Biological Vaccine Market Size by Type
9.2.1 APAC Animal Biological Vaccine Sales Quantity by Type (2018-2034)
9.2.2 APAC Animal Biological Vaccine Revenue by Type (2018-2034)
9.3 APAC Animal Biological Vaccine Market Size by Application
9.3.1 APAC Animal Biological Vaccine Sales Quantity by Application (2018-2034)
9.3.2 APAC Animal Biological Vaccine Revenue by Application (2018-2034)
9.4 APAC Animal Biological Vaccine Market Size by Region
9.4.1 APAC Animal Biological Vaccine Revenue by Region: 2018 VS 2022 VS 2034
9.4.2 APAC Animal Biological Vaccine Revenue by Region (2018-2034)
9.4.3 APAC Animal Biological Vaccine Sales Quantity by Region (2018-2034)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Animal Biological Vaccine Sales by Company
10.1.1 Middle East, Africa and Latin America Animal Biological Vaccine Sales Quantity by Company (2018-2024)
10.1.2 Middle East, Africa and Latin America Animal Biological Vaccine Revenue by Company (2018-2024)
10.2 Middle East, Africa and Latin America Animal Biological Vaccine Market Size by Type
10.2.1 Middle East, Africa and Latin America Animal Biological Vaccine Sales Quantity by Type (2018-2034)
10.2.2 Middle East, Africa and Latin America Animal Biological Vaccine Revenue by Type (2018-2034)
10.3 Middle East, Africa and Latin America Animal Biological Vaccine Market Size by Application
10.3.1 Middle East, Africa and Latin America Animal Biological Vaccine Sales Quantity by Application (2018-2034)
10.3.2 Middle East, Africa and Latin America Animal Biological Vaccine Revenue by Application (2018-2034)
10.4 Middle East, Africa and Latin America Animal Biological Vaccine Market Size by Country
10.4.1 Middle East, Africa and Latin America Animal Biological Vaccine Revenue by Country: 2018 VS 2022 VS 2034
10.4.2 Middle East, Africa and Latin America Animal Biological Vaccine Revenue by Country (2018-2034)
10.4.3 Middle East, Africa and Latin America Animal Biological Vaccine Sales Quantity by Country (2018-2034)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Israel
10.4.8 GCC Countries
11 Company Profiles
11.1 Merck
11.1.1 Merck Company Information
11.1.2 Merck Overview
11.1.3 Merck Animal Biological Vaccine Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.1.4 Merck Animal Biological Vaccine Products and Services
11.1.5 Merck Animal Biological Vaccine SWOT Analysis
11.1.6 Merck Recent Developments
11.2 Zoetis
11.2.1 Zoetis Company Information
11.2.2 Zoetis Overview
11.2.3 Zoetis Animal Biological Vaccine Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.2.4 Zoetis Animal Biological Vaccine Products and Services
11.2.5 Zoetis Animal Biological Vaccine SWOT Analysis
11.2.6 Zoetis Recent Developments
11.3 Merial/Sanofi
11.3.1 Merial/Sanofi Company Information
11.3.2 Merial/Sanofi Overview
11.3.3 Merial/Sanofi Animal Biological Vaccine Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.3.4 Merial/Sanofi Animal Biological Vaccine Products and Services
11.3.5 Merial/Sanofi Animal Biological Vaccine SWOT Analysis
11.3.6 Merial/Sanofi Recent Developments
11.4 Boehringer Ingelheim
11.4.1 Boehringer Ingelheim Company Information
11.4.2 Boehringer Ingelheim Overview
11.4.3 Boehringer Ingelheim Animal Biological Vaccine Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.4.4 Boehringer Ingelheim Animal Biological Vaccine Products and Services
11.4.5 Boehringer Ingelheim Animal Biological Vaccine SWOT Analysis
11.4.6 Boehringer Ingelheim Recent Developments
11.5 Ceva
11.5.1 Ceva Company Information
11.5.2 Ceva Overview
11.5.3 Ceva Animal Biological Vaccine Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.5.4 Ceva Animal Biological Vaccine Products and Services
11.5.5 Ceva Animal Biological Vaccine SWOT Analysis
11.5.6 Ceva Recent Developments
11.6 CAHIC
11.6.1 CAHIC Company Information
11.6.2 CAHIC Overview
11.6.3 CAHIC Animal Biological Vaccine Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.6.4 CAHIC Animal Biological Vaccine Products and Services
11.6.5 CAHIC Animal Biological Vaccine SWOT Analysis
11.6.6 CAHIC Recent Developments
11.7 HVRI
11.7.1 HVRI Company Information
11.7.2 HVRI Overview
11.7.3 HVRI Animal Biological Vaccine Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.7.4 HVRI Animal Biological Vaccine Products and Services
11.7.5 HVRI Animal Biological Vaccine SWOT Analysis
11.7.6 HVRI Recent Developments
11.8 Ringpu Biology
11.8.1 Ringpu Biology Company Information
11.8.2 Ringpu Biology Overview
11.8.3 Ringpu Biology Animal Biological Vaccine Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.8.4 Ringpu Biology Animal Biological Vaccine Products and Services
11.8.5 Ringpu Biology Animal Biological Vaccine SWOT Analysis
11.8.6 Ringpu Biology Recent Developments
11.9 Yebio
11.9.1 Yebio Company Information
11.9.2 Yebio Overview
11.9.3 Yebio Animal Biological Vaccine Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.9.4 Yebio Animal Biological Vaccine Products and Services
11.9.5 Yebio Animal Biological Vaccine SWOT Analysis
11.9.6 Yebio Recent Developments
11.10 DHN
11.10.1 DHN Company Information
11.10.2 DHN Overview
11.10.3 DHN Animal Biological Vaccine Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.10.4 DHN Animal Biological Vaccine Products and Services
11.10.5 DHN Animal Biological Vaccine SWOT Analysis
11.10.6 DHN Recent Developments
11.11 WINSUN
11.11.1 WINSUN Company Information
11.11.2 WINSUN Overview
11.11.3 WINSUN Animal Biological Vaccine Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.11.4 WINSUN Animal Biological Vaccine Products and Services
11.11.5 WINSUN Recent Developments
11.12 Elanco/Eli Lilly
11.12.1 Elanco/Eli Lilly Company Information
11.12.2 Elanco/Eli Lilly Overview
11.12.3 Elanco/Eli Lilly Animal Biological Vaccine Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.12.4 Elanco/Eli Lilly Animal Biological Vaccine Products and Services
11.12.5 Elanco/Eli Lilly Recent Developments
11.13 Virbac
11.13.1 Virbac Company Information
11.13.2 Virbac Overview
11.13.3 Virbac Animal Biological Vaccine Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.13.4 Virbac Animal Biological Vaccine Products and Services
11.13.5 Virbac Recent Developments
11.14 Jinyu Bio-Technology
11.14.1 Jinyu Bio-Technology Company Information
11.14.2 Jinyu Bio-Technology Overview
11.14.3 Jinyu Bio-Technology Animal Biological Vaccine Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.14.4 Jinyu Bio-Technology Animal Biological Vaccine Products and Services
11.14.5 Jinyu Bio-Technology Recent Developments
11.15 ChengDu Tecbond
11.15.1 ChengDu Tecbond Company Information
11.15.2 ChengDu Tecbond Overview
11.15.3 ChengDu Tecbond Animal Biological Vaccine Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.15.4 ChengDu Tecbond Animal Biological Vaccine Products and Services
11.15.5 ChengDu Tecbond Recent Developments
11.16 CAVAC
11.16.1 CAVAC Company Information
11.16.2 CAVAC Overview
11.16.3 CAVAC Animal Biological Vaccine Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.16.4 CAVAC Animal Biological Vaccine Products and Services
11.16.5 CAVAC Recent Developments
11.17 Kyoto Biken
11.17.1 Kyoto Biken Company Information
11.17.2 Kyoto Biken Overview
11.17.3 Kyoto Biken Animal Biological Vaccine Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.17.4 Kyoto Biken Animal Biological Vaccine Products and Services
11.17.5 Kyoto Biken Recent Developments
11.18 FATRO
11.18.1 FATRO Company Information
11.18.2 FATRO Overview
11.18.3 FATRO Animal Biological Vaccine Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.18.4 FATRO Animal Biological Vaccine Products and Services
11.18.5 FATRO Recent Developments
11.19 Vaksindo
11.19.1 Vaksindo Company Information
11.19.2 Vaksindo Overview
11.19.3 Vaksindo Animal Biological Vaccine Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.19.4 Vaksindo Animal Biological Vaccine Products and Services
11.19.5 Vaksindo Recent Developments
11.20 Bio-Labs
11.20.1 Bio-Labs Company Information
11.20.2 Bio-Labs Overview
11.20.3 Bio-Labs Animal Biological Vaccine Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.20.4 Bio-Labs Animal Biological Vaccine Products and Services
11.20.5 Bio-Labs Recent Developments
11.21 Avimex Animal
11.21.1 Avimex Animal Company Information
11.21.2 Avimex Animal Overview
11.21.3 Avimex Animal Animal Biological Vaccine Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.21.4 Avimex Animal Animal Biological Vaccine Products and Services
11.21.5 Avimex Animal Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Animal Biological Vaccine Value Chain Analysis
12.2 Animal Biological Vaccine Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Animal Biological Vaccine Production Mode & Process
12.4 Animal Biological Vaccine Sales and Marketing
12.4.1 Animal Biological Vaccine Sales Channels
12.4.2 Animal Biological Vaccine Distributors
12.5 Animal Biological Vaccine Customers
13 Market Dynamics
13.1 Animal Biological Vaccine Industry Trends
13.2 Animal Biological Vaccine Market Drivers
13.3 Animal Biological Vaccine Market Challenges
13.4 Animal Biological Vaccine Market Restraints
14 Key Findings
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Animal Biological Vaccine Market Size Growth Rate (CAGR) by Type, 2018 VS 2022 VS 2034 (US$ Million)
Table 2. Major Manufacturers of Oral
Table 3. Major Manufacturers of Subcutaneous
Table 4. Major Manufacturers of Intramuscular
Table 5. Major Manufacturers of Others
Table 6. Global Animal Biological Vaccine Market Size Growth Rate (CAGR) by Application, 2018 VS 2022 VS 2034 (US$ Million)
Table 7. Global Animal Biological Vaccine Revenue by Region: 2018 VS 2022 VS 2034 (US$ Million)
Table 8. Global Animal Biological Vaccine Revenue by Region (2018-2024) & (US$ Million)
Table 9. Global Animal Biological Vaccine Revenue Market Share by Region (2018-2024)
Table 10. Global Animal Biological Vaccine Revenue by Region (2024-2034) & (US$ Million)
Table 11. Global Animal Biological Vaccine Revenue Market Share by Region (2024-2034)
Table 12. Global Animal Biological Vaccine Sales Quantity by Region: 2018 VS 2022 VS 2034 (K Units)
Table 13. Global Animal Biological Vaccine Sales by Region (2018-2024) & (K Units)
Table 14. Global Animal Biological Vaccine Sales Market Share by Region (2018-2024)
Table 15. Global Animal Biological Vaccine Sales by Region (2024-2034) & (K Units)
Table 16. Global Animal Biological Vaccine Sales Market Share by Region (2024-2034)
Table 17. Global Animal Biological Vaccine Sales Quantity by Manufacturers (2018-2024) & (K Units)
Table 18. Global Animal Biological Vaccine Sales Quantity Share by Manufacturers (2018-2024)
Table 19. Global Animal Biological Vaccine Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 20. Global Animal Biological Vaccine Revenue Share by Manufacturers (2018-2024)
Table 21. Global Animal Biological Vaccine Price by Manufacturers 2018-2024 (USD/Unit)
Table 22. Global Key Players of Animal Biological Vaccine, Industry Ranking, 2021 VS 2022
Table 23. Global Animal Biological Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 24. Global Animal Biological Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Animal Biological Vaccine as of 2022)
Table 25. Global Key Manufacturers of Animal Biological Vaccine, Manufacturing Base Distribution and Headquarters
Table 26. Global Key Manufacturers of Animal Biological Vaccine, Product Offered and Application
Table 27. Global Key Manufacturers of Animal Biological Vaccine, Date of Enter into This Industry
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Animal Biological Vaccine Sales Quantity by Type (2018-2024) & (K Units)
Table 30. Global Animal Biological Vaccine Sales Quantity by Type (2024-2034) & (K Units)
Table 31. Global Animal Biological Vaccine Sales Quantity Share by Type (2018-2024)
Table 32. Global Animal Biological Vaccine Sales Quantity Share by Type (2024-2034)
Table 33. Global Animal Biological Vaccine Revenue by Type (2018-2024) & (US$ Million)
Table 34. Global Animal Biological Vaccine Revenue by Type (2024-2034) & (US$ Million)
Table 35. Global Animal Biological Vaccine Revenue Share by Type (2018-2024)
Table 36. Global Animal Biological Vaccine Revenue Share by Type (2024-2034)
Table 37. Animal Biological Vaccine Price by Type (2018-2024) & (USD/Unit)
Table 38. Global Animal Biological Vaccine Price Forecast by Type (2024-2034) & (USD/Unit)
Table 39. Global Animal Biological Vaccine Sales Quantity by Application (2018-2024) & (K Units)
Table 40. Global Animal Biological Vaccine Sales Quantity by Application (2024-2034) & (K Units)
Table 41. Global Animal Biological Vaccine Sales Quantity Share by Application (2018-2024)
Table 42. Global Animal Biological Vaccine Sales Quantity Share by Application (2024-2034)
Table 43. Global Animal Biological Vaccine Revenue by Application (2018-2024) & (US$ Million)
Table 44. Global Animal Biological Vaccine Revenue by Application (2024-2034) & (US$ Million)
Table 45. Global Animal Biological Vaccine Revenue Share by Application (2018-2024)
Table 46. Global Animal Biological Vaccine Revenue Share by Application (2024-2034)
Table 47. Animal Biological Vaccine Price by Application (2018-2024) & (USD/Unit)
Table 48. Global Animal Biological Vaccine Price Forecast by Application (2024-2034) & (USD/Unit)
Table 49. North America Animal Biological Vaccine Revenue by Company (2018-2024) & (US$ Million)
Table 50. North America Animal Biological Vaccine Sales Quantity by Company (2018-2024) & (K Units)
Table 51. North America Animal Biological Vaccine Sales Quantity by Type (2018-2024) & (K Units)
Table 52. North America Animal Biological Vaccine Sales Quantity by Type (2024-2034) & (K Units)
Table 53. North America Animal Biological Vaccine Revenue by Type (2018-2024) & (US$ Million)
Table 54. North America Animal Biological Vaccine Revenue by Type (2024-2034) & (US$ Million)
Table 55. North America Animal Biological Vaccine Sales Quantity by Application (2018-2024) & (K Units)
Table 56. North America Animal Biological Vaccine Sales Quantity by Application (2024-2034) & (K Units)
Table 57. North America Animal Biological Vaccine Revenue by Application (2018-2024) & (US$ Million)
Table 58. North America Animal Biological Vaccine Revenue by Application (2024-2034) & (US$ Million)
Table 59. North America Animal Biological Vaccine Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 60. North America Animal Biological Vaccine Revenue by Country (2018-2024) & (US$ Million)
Table 61. North America Animal Biological Vaccine Revenue by Country (2024-2034) & (US$ Million)
Table 62. North America Animal Biological Vaccine Sales Quantity by Country (2018-2024) & (K Units)
Table 63. North America Animal Biological Vaccine Sales Quantity by Country (2024-2034) & (K Units)
Table 64. Europe Animal Biological Vaccine Sales Quantity by Company (2018-2024) & (K Units)
Table 65. Europe Animal Biological Vaccine Revenue by Company (2018-2024) & (US$ Million)
Table 66. Europe Animal Biological Vaccine Sales Quantity by Type (2018-2024) & (K Units)
Table 67. Europe Animal Biological Vaccine Sales Quantity by Type (2024-2034) & (K Units)
Table 68. Europe Animal Biological Vaccine Revenue by Type (2018-2024) & (US$ Million)
Table 69. Europe Animal Biological Vaccine Revenue by Type (2024-2034) & (US$ Million)
Table 70. Europe Animal Biological Vaccine Sales Quantity by Application (2018-2024) & (K Units)
Table 71. Europe Animal Biological Vaccine Sales Quantity by Application (2024-2034) & (K Units)
Table 72. Europe Animal Biological Vaccine Revenue by Application (2018-2024) & (US$ Million)
Table 73. Europe Animal Biological Vaccine Revenue by Application (2024-2034) & (US$ Million)
Table 74. Europe Animal Biological Vaccine Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 75. Europe Animal Biological Vaccine Revenue by Country (2018-2024) & (US$ Million)
Table 76. Europe Animal Biological Vaccine Revenue by Country (2024-2034) & (US$ Million)
Table 77. Europe Animal Biological Vaccine Sales Quantity by Country (2018-2024) & (K Units)
Table 78. Europe Animal Biological Vaccine Sales Quantity by Country (2024-2034) & (K Units)
Table 79. China Animal Biological Vaccine Sales Quantity by Company (2018-2024) & (K Units)
Table 80. China Animal Biological Vaccine Revenue by Company (2018-2024) & (US$ Million)
Table 81. China Animal Biological Vaccine Sales Quantity by Type (2018-2024) & (K Units)
Table 82. China Animal Biological Vaccine Sales Quantity by Type (2024-2034) & (K Units)
Table 83. China Animal Biological Vaccine Revenue by Type (2018-2024) & (US$ Million)
Table 84. China Animal Biological Vaccine Revenue by Type (2024-2034) & (US$ Million)
Table 85. China Animal Biological Vaccine Sales Quantity by Application (2018-2024) & (K Units)
Table 86. China Animal Biological Vaccine Sales Quantity by Application (2024-2034) & (K Units)
Table 87. China Animal Biological Vaccine Revenue by Application (2018-2024) & (US$ Million)
Table 88. China Animal Biological Vaccine Revenue by Application (2024-2034) & (US$ Million)
Table 89. APAC Animal Biological Vaccine Sales Quantity by Company (2018-2024) & (K Units)
Table 90. APAC Animal Biological Vaccine Revenue by Company (2018-2024) & (US$ Million)
Table 91. APAC Animal Biological Vaccine Sales Quantity by Type (2018-2024) & (K Units)
Table 92. APAC Animal Biological Vaccine Sales Quantity by Type (2024-2034) & (K Units)
Table 93. APAC Animal Biological Vaccine Revenue by Type (2018-2024) & (US$ Million)
Table 94. APAC Animal Biological Vaccine Revenue by Type (2024-2034) & (US$ Million)
Table 95. APAC Animal Biological Vaccine Sales Quantity by Application (2018-2024) & (K Units)
Table 96. APAC Animal Biological Vaccine Sales Quantity by Application (2024-2034) & (K Units)
Table 97. APAC Animal Biological Vaccine Revenue by Application (2018-2024) & (US$ Million)
Table 98. APAC Animal Biological Vaccine Revenue by Application (2024-2034) & (US$ Million)
Table 99. APAC Animal Biological Vaccine Revenue by Region: 2018 VS 2022 VS 2034 (US$ Million)
Table 100. APAC Animal Biological Vaccine Revenue by Region (2018-2024) & (US$ Million)
Table 101. APAC Animal Biological Vaccine Revenue by Region (2024-2034) & (US$ Million)
Table 102. APAC Animal Biological Vaccine Sales Quantity by Region (2018-2024) & (K Units)
Table 103. APAC Animal Biological Vaccine Sales Quantity by Region (2024-2034) & (K Units)
Table 104. Middle East, Africa and Latin America Animal Biological Vaccine Sales Quantity by Company (2018-2024) & (K Units)
Table 105. Middle East, Africa and Latin America Animal Biological Vaccine Revenue by Company (2018-2024) & (US$ Million)
Table 106. Middle East, Africa and Latin America Animal Biological Vaccine Sales Quantity by Type (2018-2024) & (K Units)
Table 107. Middle East, Africa and Latin America Animal Biological Vaccine Sales Quantity by Type (2024-2034) & (K Units)
Table 108. Middle East, Africa and Latin America Animal Biological Vaccine Revenue by Type (2018-2024) & (US$ Million)
Table 109. Middle East, Africa and Latin America Animal Biological Vaccine Revenue by Type (2024-2034) & (US$ Million)
Table 110. Middle East, Africa and Latin America Animal Biological Vaccine Sales Quantity by Application (2018-2024) & (K Units)
Table 111. Middle East, Africa and Latin America Animal Biological Vaccine Sales Quantity by Application (2024-2034) & (K Units)
Table 112. Middle East, Africa and Latin America Animal Biological Vaccine Revenue by Application (2018-2024) & (US$ Million)
Table 113. Middle East, Africa and Latin America Animal Biological Vaccine Revenue by Application (2024-2034) & (US$ Million)
Table 114. Middle East, Africa and Latin America Animal Biological Vaccine Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 115. Middle East, Africa and Latin America Animal Biological Vaccine Revenue by Country (2018-2024) & (US$ Million)
Table 116. Middle East, Africa and Latin America Animal Biological Vaccine Revenue by Country (2024-2034) & (US$ Million)
Table 117. Middle East, Africa and Latin America Animal Biological Vaccine Sales Quantity by Country (2018-2024) & (K Units)
Table 118. Middle East, Africa and Latin America Animal Biological Vaccine Sales Quantity by Country (2024-2034) & (K Units)
Table 119. Merck Company Information
Table 120. Merck Description and Overview
Table 121. Merck Animal Biological Vaccine Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 122. Merck Animal Biological Vaccine Product and Services
Table 123. Merck Animal Biological Vaccine SWOT Analysis
Table 124. Merck Recent Developments
Table 125. Zoetis Company Information
Table 126. Zoetis Description and Overview
Table 127. Zoetis Animal Biological Vaccine Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 128. Zoetis Animal Biological Vaccine Product and Services
Table 129. Zoetis Animal Biological Vaccine SWOT Analysis
Table 130. Zoetis Recent Developments
Table 131. Merial/Sanofi Company Information
Table 132. Merial/Sanofi Description and Overview
Table 133. Merial/Sanofi Animal Biological Vaccine Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 134. Merial/Sanofi Animal Biological Vaccine Product and Services
Table 135. Merial/Sanofi Animal Biological Vaccine SWOT Analysis
Table 136. Merial/Sanofi Recent Developments
Table 137. Boehringer Ingelheim Company Information
Table 138. Boehringer Ingelheim Description and Overview
Table 139. Boehringer Ingelheim Animal Biological Vaccine Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 140. Boehringer Ingelheim Animal Biological Vaccine Product and Services
Table 141. Boehringer Ingelheim Animal Biological Vaccine SWOT Analysis
Table 142. Boehringer Ingelheim Recent Developments
Table 143. Ceva Company Information
Table 144. Ceva Description and Overview
Table 145. Ceva Animal Biological Vaccine Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 146. Ceva Animal Biological Vaccine Product and Services
Table 147. Ceva Animal Biological Vaccine SWOT Analysis
Table 148. Ceva Recent Developments
Table 149. CAHIC Company Information
Table 150. CAHIC Description and Overview
Table 151. CAHIC Animal Biological Vaccine Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 152. CAHIC Animal Biological Vaccine Product and Services
Table 153. CAHIC Animal Biological Vaccine SWOT Analysis
Table 154. CAHIC Recent Developments
Table 155. HVRI Company Information
Table 156. HVRI Description and Overview
Table 157. HVRI Animal Biological Vaccine Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 158. HVRI Animal Biological Vaccine Product and Services
Table 159. HVRI Animal Biological Vaccine SWOT Analysis
Table 160. HVRI Recent Developments
Table 161. Ringpu Biology Company Information
Table 162. Ringpu Biology Description and Overview
Table 163. Ringpu Biology Animal Biological Vaccine Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 164. Ringpu Biology Animal Biological Vaccine Product and Services
Table 165. Ringpu Biology Animal Biological Vaccine SWOT Analysis
Table 166. Ringpu Biology Recent Developments
Table 167. Yebio Company Information
Table 168. Yebio Description and Overview
Table 169. Yebio Animal Biological Vaccine Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 170. Yebio Animal Biological Vaccine Product and Services
Table 171. Yebio Animal Biological Vaccine SWOT Analysis
Table 172. Yebio Recent Developments
Table 173. DHN Company Information
Table 174. DHN Description and Overview
Table 175. DHN Animal Biological Vaccine Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 176. DHN Animal Biological Vaccine Product and Services
Table 177. DHN Animal Biological Vaccine SWOT Analysis
Table 178. DHN Recent Developments
Table 179. WINSUN Company Information
Table 180. WINSUN Description and Overview
Table 181. WINSUN Animal Biological Vaccine Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 182. WINSUN Animal Biological Vaccine Product and Services
Table 183. WINSUN Recent Developments
Table 184. Elanco/Eli Lilly Company Information
Table 185. Elanco/Eli Lilly Description and Overview
Table 186. Elanco/Eli Lilly Animal Biological Vaccine Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 187. Elanco/Eli Lilly Animal Biological Vaccine Product and Services
Table 188. Elanco/Eli Lilly Recent Developments
Table 189. Virbac Company Information
Table 190. Virbac Description and Overview
Table 191. Virbac Animal Biological Vaccine Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 192. Virbac Animal Biological Vaccine Product and Services
Table 193. Virbac Recent Developments
Table 194. Jinyu Bio-Technology Company Information
Table 195. Jinyu Bio-Technology Description and Overview
Table 196. Jinyu Bio-Technology Animal Biological Vaccine Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 197. Jinyu Bio-Technology Animal Biological Vaccine Product and Services
Table 198. Jinyu Bio-Technology Recent Developments
Table 199. ChengDu Tecbond Company Information
Table 200. ChengDu Tecbond Description and Overview
Table 201. ChengDu Tecbond Animal Biological Vaccine Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 202. ChengDu Tecbond Animal Biological Vaccine Product and Services
Table 203. ChengDu Tecbond Recent Developments
Table 204. CAVAC Company Information
Table 205. CAVAC Description and Overview
Table 206. CAVAC Animal Biological Vaccine Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 207. CAVAC Animal Biological Vaccine Product and Services
Table 208. CAVAC Recent Developments
Table 209. Kyoto Biken Company Information
Table 210. Kyoto Biken Description and Overview
Table 211. Kyoto Biken Animal Biological Vaccine Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 212. Kyoto Biken Animal Biological Vaccine Product and Services
Table 213. Kyoto Biken Recent Developments
Table 214. FATRO Company Information
Table 215. FATRO Description and Overview
Table 216. FATRO Animal Biological Vaccine Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 217. FATRO Animal Biological Vaccine Product and Services
Table 218. FATRO Recent Developments
Table 219. Vaksindo Company Information
Table 220. Vaksindo Description and Overview
Table 221. Vaksindo Animal Biological Vaccine Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 222. Vaksindo Animal Biological Vaccine Product and Services
Table 223. Vaksindo Recent Developments
Table 224. Bio-Labs Company Information
Table 225. Bio-Labs Description and Overview
Table 226. Bio-Labs Animal Biological Vaccine Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 227. Bio-Labs Animal Biological Vaccine Product and Services
Table 228. Bio-Labs Recent Developments
Table 229. Avimex Animal Company Information
Table 230. Avimex Animal Description and Overview
Table 231. Avimex Animal Animal Biological Vaccine Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 232. Avimex Animal Animal Biological Vaccine Product and Services
Table 233. Avimex Animal Recent Developments
Table 234. Key Raw Materials Lists
Table 235. Raw Materials Key Suppliers Lists
Table 236. Animal Biological Vaccine Distributors List
Table 237. Animal Biological Vaccine Customers List
Table 238. Animal Biological Vaccine Market Trends
Table 239. Animal Biological Vaccine Market Drivers
Table 240. Animal Biological Vaccine Market Challenges
Table 241. Animal Biological Vaccine Market Restraints
Table 242. Research Programs/Design for This Report
Table 243. Key Data Information from Secondary Sources
Table 244. Key Data Information from Primary Sources
List of Figures
Figure 1. Animal Biological Vaccine Product Picture
Figure 2. Global Animal Biological Vaccine Market Size Growth Rate by Type, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Animal Biological Vaccine Market Share by Type in 2022 & 2034
Figure 4. Oral Product Picture
Figure 5. Subcutaneous Product Picture
Figure 6. Intramuscular Product Picture
Figure 7. Others Product Picture
Figure 8. Global Animal Biological Vaccine Market Size Growth Rate by Application, 2018 VS 2022 VS 2034 (US$ Million)
Figure 9. Global Animal Biological Vaccine Market Share by Application in 2022 & 2034
Figure 10. Porcine
Figure 11. Poultry
Figure 12. Livestock
Figure 13. Companion Animals
Figure 14. Aquaculture
Figure 15. Animal Biological Vaccine Report Years Considered
Figure 16. Global Animal Biological Vaccine Revenue, (US$ Million), 2018 VS 2022 VS 2034
Figure 17. Global Animal Biological Vaccine Revenue 2018-2034 (US$ Million)
Figure 18. Global Animal Biological Vaccine Revenue Market Share by Region in Percentage: 2022 Versus 2034
Figure 19. Global Animal Biological Vaccine Sales Quantity 2018-2034 (K Units)
Figure 20. Global Animal Biological Vaccine Sales Quantity Market Share by Region (2018-2024)
Figure 21. Global Animal Biological Vaccine Sales Quantity Market Share by Region (2024-2034)
Figure 22. North America Animal Biological Vaccine Sales Quantity YoY (2018-2034) & (K Units)
Figure 23. North America Animal Biological Vaccine Revenue YoY (2018-2034) & (US$ Million)
Figure 24. Europe Animal Biological Vaccine Sales Quantity YoY (2018-2034) & (K Units)
Figure 25. Europe Animal Biological Vaccine Revenue YoY (2018-2034) & (US$ Million)
Figure 26. China Animal Biological Vaccine Sales Quantity YoY (2018-2034) & (K Units)
Figure 27. China Animal Biological Vaccine Revenue YoY (2018-2034) & (US$ Million)
Figure 28. APAC Animal Biological Vaccine Sales Quantity YoY (2018-2034) & (K Units)
Figure 29. APAC Animal Biological Vaccine Revenue YoY (2018-2034) & (US$ Million)
Figure 30. Middle East, Africa and Latin America Animal Biological Vaccine Sales Quantity YoY (2018-2034) & (K Units)
Figure 31. Middle East, Africa and Latin America Animal Biological Vaccine Revenue YoY (2018-2034) & (US$ Million)
Figure 32. The Top 10 and Top 5 Players Market Share by Animal Biological Vaccine Sales Quantity in 2022
Figure 33. The Top 10 and Top 5 Players Market Share by Animal Biological Vaccine Revenue in 2022
Figure 34. Animal Biological Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 35. Global Animal Biological Vaccine Sales Quantity Market Share by Type (2018-2034)
Figure 36. Global Animal Biological Vaccine Revenue Market Share by Type (2018-2034)
Figure 37. Global Animal Biological Vaccine Sales Quantity Market Share by Application (2018-2034)
Figure 38. Global Animal Biological Vaccine Revenue Market Share by Application (2018-2034)
Figure 39. North America Animal Biological Vaccine Revenue Market Share by Company in 2022
Figure 40. North America Animal Biological Vaccine Sales Quantity Market Share by Company in 2022
Figure 41. North America Animal Biological Vaccine Sales Quantity Market Share by Type (2018-2034)
Figure 42. North America Animal Biological Vaccine Revenue Market Share by Type (2018-2034)
Figure 43. North America Animal Biological Vaccine Sales Quantity Market Share by Application (2018-2034)
Figure 44. North America Animal Biological Vaccine Revenue Market Share by Application (2018-2034)
Figure 45. North America Animal Biological Vaccine Revenue Share by Country (2018-2034)
Figure 46. North America Animal Biological Vaccine Sales Quantity Share by Country (2018-2034)
Figure 47. U.S. Animal Biological Vaccine Revenue (2018-2034) & (US$ Million)
Figure 48. Canada Animal Biological Vaccine Revenue (2018-2034) & (US$ Million)
Figure 49. Europe Animal Biological Vaccine Sales Quantity Market Share by Company in 2022
Figure 50. Europe Animal Biological Vaccine Revenue Market Share by Company in 2022
Figure 51. Europe Animal Biological Vaccine Sales Quantity Market Share by Type (2018-2034)
Figure 52. Europe Animal Biological Vaccine Revenue Market Share by Type (2018-2034)
Figure 53. Europe Animal Biological Vaccine Sales Quantity Market Share by Application (2018-2034)
Figure 54. Europe Animal Biological Vaccine Revenue Market Share by Application (2018-2034)
Figure 55. Europe Animal Biological Vaccine Revenue Share by Country (2018-2034)
Figure 56. Europe Animal Biological Vaccine Sales Quantity Share by Country (2018-2034)
Figure 57. Germany Animal Biological Vaccine Revenue (2018-2034) & (US$ Million)
Figure 58. France Animal Biological Vaccine Revenue (2018-2034) & (US$ Million)
Figure 59. U.K. Animal Biological Vaccine Revenue (2018-2034) & (US$ Million)
Figure 60. Italy Animal Biological Vaccine Revenue (2018-2034) & (US$ Million)
Figure 61. Russia Animal Biological Vaccine Revenue (2018-2034) & (US$ Million)
Figure 62. China Animal Biological Vaccine Sales Quantity Market Share by Company in 2022
Figure 63. China Animal Biological Vaccine Revenue Market Share by Company in 2022
Figure 64. China Animal Biological Vaccine Sales Quantity Market Share by Type (2018-2034)
Figure 65. China Animal Biological Vaccine Revenue Market Share by Type (2018-2034)
Figure 66. China Animal Biological Vaccine Sales Quantity Market Share by Application (2018-2034)
Figure 67. China Animal Biological Vaccine Revenue Market Share by Application (2018-2034)
Figure 68. APAC Animal Biological Vaccine Sales Quantity Market Share by Company in 2022
Figure 69. APAC Animal Biological Vaccine Revenue Market Share by Company in 2022
Figure 70. APAC Animal Biological Vaccine Sales Quantity Market Share by Type (2018-2034)
Figure 71. APAC Animal Biological Vaccine Revenue Market Share by Type (2018-2034)
Figure 72. APAC Animal Biological Vaccine Sales Quantity Market Share by Application (2018-2034)
Figure 73. APAC Animal Biological Vaccine Revenue Market Share by Application (2018-2034)
Figure 74. APAC Animal Biological Vaccine Revenue Share by Region (2018-2034)
Figure 75. APAC Animal Biological Vaccine Sales Quantity Share by Region (2018-2034)
Figure 76. Japan Animal Biological Vaccine Revenue (2018-2034) & (US$ Million)
Figure 77. South Korea Animal Biological Vaccine Revenue (2018-2034) & (US$ Million)
Figure 78. China Taiwan Animal Biological Vaccine Revenue (2018-2034) & (US$ Million)
Figure 79. Southeast Asia Animal Biological Vaccine Revenue (2018-2034) & (US$ Million)
Figure 80. India Animal Biological Vaccine Revenue (2018-2034) & (US$ Million)
Figure 81. Middle East, Africa and Latin America Animal Biological Vaccine Sales Quantity Market Share by Company in 2022
Figure 82. Middle East, Africa and Latin America Animal Biological Vaccine Revenue Market Share by Company in 2022
Figure 83. Middle East, Africa and Latin America Animal Biological Vaccine Sales Quantity Market Share by Type (2018-2034)
Figure 84. Middle East, Africa and Latin America Animal Biological Vaccine Revenue Market Share by Type (2018-2034)
Figure 85. Middle East, Africa and Latin America Animal Biological Vaccine Sales Quantity Market Share by Application (2018-2034)
Figure 86. Middle East, Africa and Latin America Animal Biological Vaccine Revenue Market Share by Application (2018-2034)
Figure 87. Middle East, Africa and Latin America Animal Biological Vaccine Sales Quantity Share by Country (2018-2034)
Figure 88. Middle East, Africa and Latin America Animal Biological Vaccine Revenue Share by Country (2018-2034)
Figure 89. Brazil Animal Biological Vaccine Revenue (2018-2034) & (US$ Million)
Figure 90. Mexico Animal Biological Vaccine Revenue (2018-2034) & (US$ Million)
Figure 91. Turkey Animal Biological Vaccine Revenue (2018-2034) & (US$ Million)
Figure 92. Israel Animal Biological Vaccine Revenue (2018-2034) & (US$ Million)
Figure 93. GCC Countries Animal Biological Vaccine Revenue (2018-2034) & (US$ Million)
Figure 94. Animal Biological Vaccine Value Chain
Figure 95. Animal Biological Vaccine Production Process
Figure 96. Channels of Distribution (Direct Vs Distribution)
Figure 97. Distributors Profiles
Figure 98. Bottom-up and Top-down Approaches for This Report
Figure 99. Data Triangulation
Figure 100. Key Executives Interviewed